• SELECT SITE CURRENCY
Select a currency for use throughout the site
Blood Glucose Monitoring Market in the US 2011-2015
Infiniti Research Limited, July 2012, Pages: 46
TechNavio's analysts forecast the Blood Glucose Monitoring Device market in the US to grow at a CAGR of 3.8 percent over the period 2011-2011. One of the key factors contributing to this market growth is the introduction of personal testing kits. The Blood Glucose Monitoring Device market in the US has also witnessed the adoption of continuous glucose monitoring systems. However, the unwillingness of diabetes patients to use blood glucose monitoring devices could pose a challenge to the growth of this market.
TechNavio's report, the Blood Glucose Monitoring Device Market in the US 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report focuses on the US market; it also covers the Blood Glucose Test Strips, Blood Glucose Meters, and Lancets market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Bayer Healthcare, LifeScan Inc., Medtronic Inc., and Roche Diagnostics. Other vendors mentioned in the report: Abbott Laboratories, Arkray Inc., Braun Melsungen AG, Dexcom, GlySens Inc., Hainice Medical Inc., Nipro, Diagnostics Inc., Nova Biomedical, and Terumo Corporation.
Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report
TechNavio Announces the Publication of its Report - Blood Glucose Monitoring Market in the US 2011-2015
TechNavio today launched its report Blood Glucose Monitoring Market in the US 2011-2015 based on an in-depth study focusing exclusively on the US. The report aims to aid decision makers’ understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said; “Vendors have developed continuous glucose monitoring equipment that has a sensor and a transmitter. The equipment is placed on the body and interfaced with a wireless monitor, which receives the data on a periodic basis. This equipment is becoming popular among diabetic patients and it is expected to have a strong impact on the Blood Glucose Monitoring (BGM) Device market in the US.”
According to the report, vendors have developed smaller BGM devices that are portable, and presently they are sold in retail markets and pharmacies across the US. Vendors have begun to introduce personal testing kits that have a BGM device, a bundle of test strips, and other consumables, and these are becoming popular across the US. This driver is expected to have a strong impact on the market in the future.
Further, the report also discusses that the inaccuracy of devices is a major challenge hindering this market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
01. Executive Summary
03. Market Coverage
04. Market Landscape
Key Market Segments
04.1 Blood Glucose Test Strips Market in the US
04.2 Blood Glucose Meters Market in the US
04.3 Lancets Market in the US
Blood Glucose Monitoring Device Market in the US by Forecast of Key Market Segmentation
Treatment Methods for Diabetic Patients
Major Complications due to Diabetes among the US Population
Five Forces Analysis
05. Rate of Incidence and Prevalence
06. Vendor Landscape
Product Portfolio Matrix
07. Buying Criteria
08. Market Growth Drivers
09. Drivers and their Impact
Impact of Drivers on End-user Category
10. Market Challenges
11. Impact of Drivers and Challenges
12. Market Trends
13. Key Vendor Analysis
13.1 LifeScan Inc.
13.2 Roche Diagnostics
13.3 Bayer Healthcare
13.4 Medtronic Inc.
13.5 Abbott Laboratories
14. Other Reports in this Series
List of Exhibits:
Exhibit 1: Blood Glucose Monitoring Device Market in the US by Market Segmentation
Exhibit 2: Blood Glucose Monitoring Device Market in the US 2011-2015 (US$ million)
Exhibit 3: Blood Glucose Monitoring Device Market in the US by Key Market Segmentation 2011
Exhibit 4: Blood Glucose Test Strips Market in the US 2011-2015 (US$ million)
Exhibit 5: Blood Glucose Meters Market in the US 2011-2015 (US$ million)
Exhibit 6: Lancets Market in the US 2011-2015 (US$ million)
Exhibit 7: Blood Glucose Monitoring Device Market in the US by Forecast of Key Market Segmentation 2011-2015 (US$ million)
Exhibit 8: Blood Glucose Monitoring Device Market in the US by Market Forecast Segmentation (2011-2015)
Exhibit 9: Blood Glucose Monitoring Devices Market in the US by Treatment Methods
Exhibit 10: Major Complications among Diabetic Population in the US (percentage)
Exhibit 11: Blood Glucose Monitoring Device Market in the US by Vendor Segmentation 2011
- Bayer Healthcare
- LifeScan Inc.
- Medtronic Inc.
- Roche Diagnostics
- Abbott Laboratories
- Arkray Inc.
- Braun Melsungen AG
- GlySens Inc.
- Hainice Medical Inc.
- Diagnostics Inc.
- Nova Biomedical
- Terumo Corporation.